NEW YORK (Reuters Health) – The bone anabolic drug teriparatide is more effective than alendronate at increasing bone mineral density (BMD) and preventing vertebral fractures in patients with…
NEW YORK (Reuters Health) – More than half of women in a recent survey had undiagnosed urinary incontinence, with two thirds reporting moderate to severe symptoms. Because urinary…
NEW YORK (Reuters Health) – MRI of the breast has the greatest potential, compared with digital mammography or whole-breast ultrasound, for detecting cancers missed by film screen mammogram,…
Charles Lockwood, MD, Professor and Chair, Dept. of Obstetrics, Gynecology & Reproductive Services, Yale School of Medicine, describes the current research at one of the nation’s top programs.…
Hugh S. Taylor, MD, is Professor of Obstetrics, Gynecology and Reproductive Sciences, and Director of Reproductive Endocrinology and Infertility at the Yale University School of Medicine discusses the…
NEW YORK (Reuters Health) – In women treated for small (1 cm or less), node-negative breast cancers, HER2 positivity is strongly linked to recurrence and poorer disease-free survival,…
NEW YORK (Reuters Health) – Women who lie on their backs for 15 minutes after intrauterine insemination have a better chance of becoming pregnant than women who move…
NEW YORK (Reuters Health) – Women who regularly use nonsteroidal anti-inflammatory drugs (NSAIDs) have better survival after a colorectal cancer (CRC) diagnosis, research indicates. “A wide body of…
NEW YORK (Reuters Health) – Liquid-based cytology is no better than conventional Pap tests in detecting cervical cancer precursors, according to a report in the Journal of the…
NEW YORK (Reuters Health) – In postmenopausal women with osteopenia, zoledronic acid, given either once-yearly or as a single infusion, is well tolerated and effective in preventing bone…